You arrive at the gym and find yourself at a familiar crossroads: Turn this way for the weight room, or that way for the cardio deck. You planned to do both—but which should you do first? Does it even ...

Credit: Getty Images By reinforcing the essential role of exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and improves functional health.

Barbell training gave me a new perspective on aging. By Lisa Miller Not to be all Russell Crowe about it, but this morning, I biked to the gym before dawn, loaded up a barbell and did three sets of ...

Known for her openness about weight loss and wellness in the public eye, Heather Gay is sharing her story of how Atkins has helped her navigate the challenges of GLP-1 use. "I've been really vocal ...

A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a high-fidelity "dry" simulator for endoscopic submucosal dissection (ESD). ESD is ...

People who stop taking weight-loss injections such as Wegovy and Mounjaro regain pounds much faster than those who halt exercising and dieting, a new medical study shows. Research published in The ...

At this point, millions of people in the U.S. have tried at least one of a variety of glucagonlike peptide 1 (GLP-1) receptor agonist drugs such as Zepbound or Wegovy. For some, these medications have ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...